Navigation Links
Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
Date:12/14/2007

bserved with the combination of forodesine HCl and bendamustine in these in vitro experiments.

"We believe the encouraging clinical data presented by Dr. Duvic support the further development of forodesine HCl as a single agent and further validate our ongoing pivotal trial in patients with CTCL," said Jon P. Stonehouse, President and CEO of BioCryst. "Additionally, the data from Dr. Gil's laboratory suggest a therapeutic potential for forodesine HCl as a single agent as well as in combination with bendamustine as potentially effective therapeutic options in the treatment of CLL."

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life- threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization of BCX-4208, and is collaborating with Mundipharma for the development and commercialization of forodesine HCl in markets across Europe, Asia, Australia and certain neighboring countries. In January, 2007 the U.S. Department of Health and Human Services (DHHS) awarded a $102.6 million, four-year contract to BioCryst for advanced development of peramivir to treat seasonal and life-threatening influenza. In February 2007 BioCryst established a partnership with Shionogi & Co., to develop and commercialize peramivir in Japan. For more information about BioCryst, please visit the company's web site at http://www.biocryst.com.

Forward-looking statements

This press release contains forward-looking statements, including statements regarding future re
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasd...gproductsforminimallydisruptivesurgicaltreatmentsf...andChiefExecutiveOfficer,andMichaelJ.Lambert,Execu...uledtopresentatthe21stAnnualPiperJaffrayHealthCare...dnesday,December2,2009,at10:00a.m.ET.Mr.Lukianovan...
(Date:11/23/2009)...MOND,Calif.,Nov.23/PRNewswire-FirstCall/--Transcep...thatitisscheduledtomeetwiththeU.S.FoodandDrugAdmin...ResponseLetterregardingtheNewDrugApplication(NDA)f...ablet).Aspreviouslyannounced,theCompleteResponseLe...thattheFDAcouldnotapprovetheNDAinitspresentform.Th...
(Date:11/23/2009)...,Mass.,Nov.23/PRNewswire/--LigonDiscovery,Inc.,whi...tofinddrugsagainsthigh-valuetargets,todayannounced...B.DeSouzaasLigon,sExecutiveChairmanoftheBoard. ,...ChairmanoftheBoard,"saidPatrickKleyn,Ligon,schiefe...thofexperienceinthelifesciencesindustry--particula...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 3Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2Cardiac arrest resuscitation 3A Passive oxygen flow better than assisted ventilation 9547 1Cardiac arrest resuscitation 3A Passive oxygen flow better than assisted ventilation 9547 2Australian filmmakers are stars of science film awards 9545 1Australian filmmakers are stars of science film awards 9545 2Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 1Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 2
...-six-year-old,Keith Hora went to see Dr. Peter Her...versity of Newcastle in Australia, he was told he ...n diagnosed with stage III melanoma, one,of the mo...had multiple melanoma reoccurrences in the previou...ng him, including multiple surgeries,to remove the...
...,released today by Trust for America,s Health:, W...ew report from the,American Academy of Pediatrics ...mic Influenza: Warning, Children At-Risk." The rep...ng and caring for children during a possible,pande... AAP and TFAH for,how to address those gaps., WHE...
Other Medicine Technology:Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years 2
(Date:11/24/2009)... Community-associated strains have increased seven... (HealthDay News) -- Strains of antibiotic-resista...increasingly showing up among hospital outpatients...fected, new research says. , From 1999 to 2006,...idence of outpatients with methicillin-resistant ...
(Date:11/24/2009)..., Laser-type device to be... San Diego, CA (PRWEB) November 24, 2009 ...ed that it has initiated discussions with a manufa...oprietary laser device which shall be owned by Ent... therapies currently being developed by Entest. Th...
(Date:11/24/2009)..., Several Tips to Get a L...ion , Bethesda, Md. (Vocu...etween 8,000-10,000 steps a day—but that num...on. As expert and rookie travelers alike continue ... to forget that the feet often bear the brunt of a...
(Date:11/24/2009)...,, WASHINGTON,Nov.24/PRNewswire/--MinuteClin...hcareintheUnitedStates,hasopeneditsfirstretailheal...oreonBladensburgRoad.Theclinicisopensevendaysaweek...dingTrinidad,CarverLangston,KingmanPark,AtlasDistr..."Throughthisconvenientlylocatedstore-basedclinic,w...
(Date:11/24/2009)...,, COLUMBUS,Ga.,Nov.24/PRNewswire-FirstCall/...heLloydsBankingGroupplchasacceptedtheexchangeoftwo...fferprogramwasannouncedbyLloydsonNovember3,2009,an...,, Whenthetransactionsettles,Aflacwillhaveexcha...,UpperTierIIperpetualsecurities(parvalueof$222mill...
Breaking Medicine News(10 mins):Health News:MRSA Creeping Into Hospitals From the Outside 2Health News:MRSA Creeping Into Hospitals From the Outside 3Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4
...says many smokers are yet to understand the risks ...pictures are an effective// way to get the message...lth, Damien O'Connor, today launched a proposal fo...60% of cigarette packs. They announced on Wednesda...
...siness (ISB) Tuesday signed a memorandum of unders...based real estate company, to establish// the firs...s'. This is said to be the first such step ...Centre for Entrepreneurial Development (WCED). ...
... gene that increased Type 2 diabetes in overweight...eatment for the condition in humans. // Type...on, with an estimated 16 million Americans afflict...dison studied obese mice and discovered the gene, ...
...fiber is perhaps the first thing that doctors and ...ng hemorrhoids. // Hemorrhoids, a condition charac...ound the anus that can give rise to bleeding and u..., chronic constipation or diarrhea, overuse of lax...
...ll Clinton is on a different trip. Bill Clinton ha...ill grew up on rich, fat laden diets that did not ...tead landed him in serious health trouble, leading...r lot! Major players have joined hands in this ...
...ue Smarties will no longer fascinate kids after ma...ificial coloring from them//. Nestlé said that it ...ations that have expressed fears that the artifici...nce in kids. "The thing about blue is there are no...
Other Medicine News:Health News:New Zealand To Issue Graphic Warnings In Cigarette Packs 2
Eye Speculum-Wire Blade
Needle Holder (Without Lock)
Manipulator/Chopper (Centered)
Iris Spatula (Barraquer Iris Spatula)
Medicine Products: